CYP1A2: whether coffee is working for you or against you

• GeneCYP1A2, a liver cytochrome P450 enzyme
• Variant testedrs762551 (-163C>A)
• What it controlsHow quickly caffeine is cleared from your blood
• Population splitAbout 41% fast (AA), 44% intermediate, 15% slow (CC)
• What changesCaffeine timing guidance, and B-vitamin and antioxidant load

What the gene does

CYP1A2 builds the enzyme that demethylates caffeine in the liver. It handles the overwhelming majority of the job, which is unusual: most compounds are cleared by several routes at once. Here one gene does nearly all of it, which is why a single variant has such a visible effect.

What the variant changes

rs762551 sits in the first intron and changes how strongly the gene is induced. A/A carriers clear caffeine quickly. C-carriers hold onto it, so the same cup circulates longer and at a higher effective concentration.

The research here is unusually clean for nutrigenetics. In a case-control study, slow metabolisers under 59 drinking four or more cups a day had more than double the odds of myocardial infarction, while fast metabolisers showed no such association and in some analyses appeared protected. A separate cohort found nearly threefold higher hypertension incidence in slow metabolisers drinking more than three cups a day.

What it means for you

If you're a slow metaboliser, the useful move is a ceiling and a cut-off time rather than giving up coffee. Afternoon caffeine is the part that tends to matter, both for blood pressure and for sleep. It's also worth counting the hidden sources: tea, cola, energy drinks and some painkillers.

If you're fast, you have more room, though the ceiling still exists and it's personal.

What your formula does

Caffeine clearance interacts with several nutrients your formula covers. Heavy coffee intake affects B-vitamin turnover and the antioxidant load your system carries, and your genotype feeds into those totals rather than sitting in the report as a standalone fact.

← Back to the science